Back to Portfolio
BBW

BBW

$11.29 SGD 339M market cap February 22, 2026
Azeus Systems Holdings Ltd. BBW BUFFETT / MUNGER / KLARMAN SUMMARY
1 SNAPSHOT
Price$11.29
Market CapSGD 339M
EVSGD 292M
Net DebtSGD -47M (net cash HK$270M)
Shares30.0M
2 BUSINESS

Azeus is a Hong Kong-headquartered, Singapore-listed software company that develops Convene, an award-winning board governance platform used by thousands of organizations in 100+ countries. The company also provides IT services to the Hong Kong government and won a transformative HK$1.02 billion CERKS electronic recordkeeping contract. Revenue is ~91% recurring/contracted with 82.5% from proprietary products and 17.5% from IT services.

Revenue: HKD 474.8M (SGD 82.6M) Organic Growth: 44.3% (FY2025); 9.5% (H1 FY2026)
3 MOAT NARROW

Switching costs are the primary moat: board portal software is deeply embedded in governance workflows, requiring board-level approval to change. Regulatory moat from CMMI Level 5 certification (20+ years), ISO 27001, SOC 2 Type II, and government-grade security clearances. The CERKS contract creates a 10-year lock-in with Hong Kong government. Gross margins expanding from 69% to 77% over 5 years demonstrates pricing power. However, Diligent is 10x larger and the category shows feature convergence risk.

4 MANAGEMENT
CEO: Michael Yap Kiam Siew (since 2022)

Near-100% dividend payout ratio with zero debt and no acquisitions. Founder/ Chairman Lee Wan Lik (MIT, 1991 founder) controls 82.4% of shares and is deeply aligned. The extreme payout reflects asset-light operations and founder preference to distribute earnings. No share dilution or buybacks. R&D investment at HK$40M/year (8.3% of revenue) funds product development.

5 ECONOMICS
41.7% (FY2025 peak); 25.8% (H1 FY2026 normalized) Op Margin
>100% (minimal tangible invested capital) ROIC
HKD 194.4M (FY2025) FCF
-1.4x (net cash position) Debt/EBITDA
6 VALUATION
FCF/ShareHKD 6.48 (SGD 1.13)
FCF Yield10.2%
DCF RangeSGD 9.20 - SGD 17.50

Base case: 8% FCF growth for 5 years, 5% for years 6-10, 2.5% terminal growth, 12% discount rate (includes illiquidity premium). Net cash of HK$270M added. Bear case uses 6% growth and 13% discount rate.

7 MUNGER INVERSION -61.5%
Kill Event Severity P() E[Loss]
CERKS revenue cliff post-FY2027 as implementation phase ends -30% 70% -21.0%
H1 FY2026 deceleration persists; growth stalls permanently -25% 50% -12.5%
Extreme illiquidity causes forced selling / price dislocation -30% 40% -12.0%
Key-man risk: Founder Lee Wan Lik departs or health issue -40% 15% -6.0%
Competitive displacement by Diligent or Nasdaq Boardvantage -25% 20% -5.0%
Hong Kong political risk affecting government contracts -20% 25% -5.0%

Tail Risk: Correlated scenario: CERKS winds down, Convene growth stalls due to competitive pressure, and the Hong Kong political environment deteriorates simultaneously. In this tail case, earnings could halve to ~HK$80M and the P/E could compress to 8x, implying a stock price of SGD 5-6 (-45-55% decline). The 17% float amplifies any downside.

8 KLARMAN LENS
Downside Case

In the bear case, CERKS implementation revenue runs off by FY2027, organic Convene growth slows to single digits as larger competitors gain share, and normalized earnings settle around HK$80-100M. At an 8-10x P/E, this implies a SGD 5-7 stock price. The dividend would need to be cut substantially.

Why Market Wrong

The market may be undervaluing the durability of Convene's recurring SaaS revenue base. Even excluding CERKS, the product segment has been growing 20%+ organically. The 77% gross margin and 100+ country footprint suggest a genuine software franchise, not a one-off contract play. Net cash of HK$270M (14% of market cap) provides downside protection.

Why Market Right

H1 FY2026 results (-1.1% net income, 25.8% margins) may be the first sign that CERKS peak earnings are behind us. The 17% float makes the stock essentially uninvestable for institutions. The 99% payout ratio leaves zero buffer for earnings decline. Geographic concentration in Hong Kong adds political risk that is difficult to quantify.

Catalysts

New large government contract win (digital records, social care, etc.); acceleration of Convene subscription growth in new markets (Americas, EMEA); strategic partnership or white-label agreement; increase in public float via secondary offering; AI-powered governance features driving premium pricing.

9 VERDICT WAIT
A- T2 Resilient
Strong Buy$9
Buy$10
Sell$17

Azeus Systems is an exceptional quality business (A-grade) trading at reasonable but not compelling valuations. The 12x P/E and 8% dividend yield are attractive, but H1 FY2026 deceleration, CERKS revenue cliff risk, extreme illiquidity (17% float), and near-100% payout ratio create meaningful near-term uncertainty. Accumulate below SGD 9.50 for a 2-3% portfolio position where FCF yield exceeds 12% and provides adequate margin of safety.

🧠 ULTRATHINK Deep Philosophical Analysis

BBW - Ultrathink Analysis

The Real Question

The real question is not whether Azeus is a good business -- it manifestly is. The 77% gross margins, zero debt, and founder-operator with 82% ownership tell that story unambiguously. The real question is whether we are witnessing the peak of a one-time contract windfall, or the early innings of a durable software franchise that happens to have been turbo-charged by the CERKS contract.

This is the distinction that will determine whether BBW at SGD 11 is a bargain or a value trap.

Hidden Assumptions

The market appears to be making two contradictory assumptions simultaneously, which is why the stock is mispriced in either direction.

The bull assumption: FY2025's HK$475M revenue and HK$167M net income represent a new baseline from which Azeus will continue growing. At 12x this earnings power, the stock is absurdly cheap for a 77% gross margin software company. This assumption ignores that perhaps HK$100M+ of FY2025 revenue came from one-time CERKS implementation milestones.

The bear assumption: H1 FY2026's flat earnings are the canary in the coal mine. CERKS is winding down, Convene organic growth cannot fill the gap, and the stock is actually trading at 20x+ normalized earnings. This assumption ignores that the Convene product business has been consistently growing 20-30% ex-CERKS, and that the CERKS maintenance phase will add HK$38M/year in high-margin recurring revenue for a decade.

The truth lies in the space between these narratives. The critical variable is what Convene subscription revenue looks like stripped of CERKS -- and the annual reports do not disaggregate this with sufficient clarity to know precisely.

The Contrarian View

For the bears to be right, several things would need to be true simultaneously:

  1. Convene's organic growth is slowing. The board portal market is maturing, Diligent's scale advantage is insurmountable, and Azeus has largely saturated its addressable market in Asia/Middle East. The 100+ countries figure is misleading -- most of those markets have only a handful of clients.

  2. The CERKS afterglow is temporary. The record-keeping system, once deployed, will not generate meaningful upsell opportunities. The Hong Kong government is a one-off client, not a reference customer that unlocks other governments.

  3. The high margins are unsustainable. FY2025's 42% operating margin was an anomaly driven by high-margin licensing recognition. The H1 FY2026 operating margin of 26% is the real number, and it will compress further as the company must invest more in sales and marketing to compete globally.

  4. The payout ratio signals limited growth opportunities. Management is distributing 99% of earnings because they see no productive way to reinvest in the business. This is a cash cow in slow decline, not a growth platform.

If all four are true, BBW is worth SGD 6-7, and the current price offers no margin of safety. I estimate the probability of all four being simultaneously true at about 20%.

Simplest Thesis

Azeus Systems is a founder-owned software company with world-class margins and genuine switching costs, temporarily obscured by noise from a large government contract, trading at 10x cash-adjusted earnings.

Why This Opportunity Exists

The mispricing exists for structural reasons that are unlikely to self-correct quickly:

Liquidity desert. With only 17% public float and 6,000 shares/day average volume, this stock is invisible to institutional investors. No fund manager can build a meaningful position without moving the price 20%. This structural exclusion from institutional portfolios means the stock is permanently under-owned relative to its quality.

Reporting opacity. The company reports in HKD but trades in SGD, is incorporated in Bermuda, headquartered in Hong Kong, and listed in Singapore. This jurisdictional complexity deters most retail investors. There is zero sell-side analyst coverage. The annual report does not cleanly disaggregate Convene subscription ARR from CERKS implementation revenue, making it impossible for casual observers to assess the underlying trajectory.

Size and geography. At SGD 339M market cap, Azeus falls below every institutional threshold. Its primary market (Hong Kong) is perceived as politically risky. Its competitors are private (Diligent) or embedded in larger companies (Nasdaq), making peer valuation comparison difficult.

Founder control paradox. The 82% insider ownership that signals alignment also creates the illiquidity that suppresses valuation. This is a catch-22 common to founder-led Asian small caps.

These structural factors are persistent, meaning the stock may remain cheap for years. The question is whether the underlying business compounds fast enough to reward patient holders through dividends and intrinsic value growth, even without multiple expansion.

At 8.2% dividend yield and 10%+ FCF yield, the answer is probably yes -- provided earnings do not deteriorate significantly from here.

What Would Change My Mind

My thesis would be invalidated by any of the following concrete, falsifiable outcomes:

  1. FY2026 full-year revenue below HK$350M. This would indicate that CERKS revenue is disappearing faster than Convene can grow, and normalized earnings power is materially lower than I estimate. The stock would be expensive, not cheap.

  2. Operating margins below 20% for two consecutive half-years. This would suggest the high-margin software model is eroding and the business is reverting to lower-margin IT services economics.

  3. Lee Wan Lik sells a meaningful portion of his stake. The founder's 82% ownership is the single strongest signal of alignment. Any reduction would fundamentally change the thesis. Note: given the estate structure (Mu Xia Ltd, Lam Pui Wan estate), any restructuring of these holdings deserves careful scrutiny but is not automatically bearish.

  4. A major competitive win by Diligent in Azeus' core Asian/Middle Eastern markets. If Convene is displaced from government accounts or large enterprise clients in its home markets, the switching cost moat is not as strong as hypothesized.

  5. Dividend cut combined with no new growth investment. If management cuts the dividend but does not redeploy capital into growth (e.g., acquisitions, new product development, geographic expansion), it signals deteriorating economics with no strategic response.

The Soul of This Business

At its core, Azeus Systems is a craftsman's company. Lee Wan Lik founded it 35 years ago as a software engineering firm and has maintained CMMI Level 5 certification for two decades -- a feat that requires genuine institutional discipline, not just marketing puffery. This is a company that takes engineering quality seriously in an industry drowning in vaporware and hype.

The competitive position is both inevitable and fragile. It is inevitable in the sense that once Convene is embedded in a board's governance workflow, the switching costs create a natural monopoly within that client. Directors do not want to learn new software. Compliance teams do not want to re-certify. IT departments do not want to migrate historical records. The friction of change protects the installed base.

It is fragile in the sense that Azeus is small. Diligent, backed by Insight Partners with over a billion dollars in revenue, could theoretically subsidize below-cost pricing to win new clients. The board portal market is not winner-take-all, but it does reward scale in sales, marketing, and product development. Azeus compensates with engineering excellence and government-grade compliance, but these advantages are not permanent moats -- they are walls that must be continuously maintained.

The CERKS contract is both a blessing and a curse. It blessed the company with transformative revenue and a showcase project (an "All-of-Government" digital recordkeeping system is a powerful reference). It cursed the company with a revenue peak that may be difficult to replicate, creating expectations that organic growth cannot satisfy.

The question for patient investors is whether the Convene SaaS franchise -- stripped of CERKS, stripped of Hong Kong government contracts -- is a 20% growth, 30% margin business worth 15-20x earnings, or a 10% growth, 25% margin business worth 10-12x earnings. The former implies SGD 15+; the latter implies the current price is roughly fair.

I lean toward the latter interpretation, which is why WAIT is the right call. But at SGD 9-10, where the cash-adjusted P/E drops to ~8-9x and the dividend yield exceeds 10%, the margin of safety becomes compelling enough to act. Patience, as always, is the investor's greatest edge.

Executive Summary

3-Sentence Investment Thesis

Azeus Systems Holdings is a founder-led, asset-light software company with an extraordinary franchise in board governance software (Convene) serving 100+ countries, generating 77% gross margins and 41% operating margins with zero debt and HK$270M in net cash. The HK$1.02 billion CERKS government contract provides revenue visibility through FY2027, while the recurring SaaS product business offers durable competitive advantages through switching costs, regulatory compliance requirements, and CMMI Level 5 certification. However, the stock's 17% public float creates severe liquidity risk, H1 FY2026 results show material deceleration (revenue +9.5%, net income -1.1%), and geographic concentration in Hong Kong/Asia (63.5% of revenue) introduces political and client concentration risk that warrants a patient entry strategy.

Key Metrics Dashboard

Metric Value Assessment
P/E (TTM) 12.3x Attractive for quality software
EV/EBITDA ~8x Cheap (net cash adjusted)
FCF Yield ~10.2% Very high
ROE (FY2025) 74.5% Exceptional
Gross Margin 76.6% Elite software-tier
Operating Margin 41.7% Outstanding
Net Debt HK$-270M (net cash) Fortress balance sheet
Dividend Yield 8.2% Extremely high
Payout Ratio ~99% Unsustainably high
Revenue CAGR (5yr) 21.7% Strong
Public Float 17.3% Critically low

Verdict

WAIT - Accumulate on weakness below SGD 9.50. The business quality is exceptional (A-grade), but H1 FY2026 deceleration, CERKS revenue cliff risk post-FY2027, extreme illiquidity, and the ~100% payout ratio create near-term uncertainty. The stock has already fallen ~35% from its 52-week high, suggesting the market is pricing in some of these concerns. Patient investors should build a position gradually, buying on pullbacks to the SGD 9-10 range where the FCF yield exceeds 12-13%.


Phase 0: Business Understanding

What Does Azeus Do?

Azeus Systems Holdings is a Hong Kong-headquartered, Singapore-listed software and IT services company founded in 1991 by Lee Wan Lik, an MIT-educated computer scientist who previously worked at Oracle. The company operates in two segments:

1. Azeus Products (82.5% of revenue, FY2025)

  • Convene Board Portal: Award-winning SaaS platform for board meetings, governance, and collaboration. Used by boards, committees, and leadership teams in 100+ countries across Fortune 500 companies, regulatory bodies, universities, banks, and NGOs. Features include secure document sharing, virtual/hybrid meeting support, AI-powered meeting assistance, Microsoft Teams integration, ESG reporting, and AGM management.
  • Convene Records: Next-generation records management solution. The backbone of the HK$1.02 billion CERKS contract with the Hong Kong government.
  • AzeusCare: Purpose-built social care case management platform for UK local councils.

2. IT Services (17.5% of revenue, FY2025)

  • Custom IT consultancy, systems implementation, and maintenance/support services
  • Primarily serves Hong Kong government agencies
  • 63.9% of IT Services revenue (HK$53M) is recurring maintenance contracts
  • The Group has managed IT professional services for the Office of Government CIO of Hong Kong since 2007

How Does Azeus Make Money?

The revenue model is increasingly SaaS/subscription-driven:

Revenue Stream FY2025 (HK$M) % Nature
Product licensing (subscription + CERKS) 334.2 70.4% Recurring/contracted
Product service revenue 40.5 8.5% Recurring
IT maintenance & support 53.0 11.2% Recurring
Systems implementation 42.6 9.0% Project-based
Product M&S 4.5 0.9% Recurring
Total 474.8 100% ~91% recurring/contracted

The critical insight: approximately 91% of revenue is either recurring subscription/SaaS or under multi-year government contracts. This is not a lumpy project-based IT services firm -- it is predominantly a product company.

The CERKS Contract: A Transformative Win

In FY2023, Azeus won the HK$1.02 billion Central Electronic Record Keeping System (CERKS) contract from the Hong Kong Government -- the largest in company history:

  • Implementation: HK$633.9M over 53 months (through FY2027)
  • Maintenance & Support: HK$381.4M over 10 years post-deployment
  • Based on Azeus' proprietary Convene Records platform
  • Currently in deployment phase across government departments and bureaus
  • This single contract represents roughly 2x the company's pre-CERKS annual revenue

Geographic Diversification

Region FY2025 Revenue % Growth YoY
Hong Kong & Asia HK$301.7M 63.5% +60.9%
UK & Europe HK$54.4M 11.5% +16.5%
Middle East HK$51.1M 10.8% +37.2%
Africa HK$25.4M 5.4% +26.8%
Australia & NZ HK$21.4M 4.5% +5.9%
Americas HK$20.7M 4.4% +20.4%

Hong Kong/Asia dominance (63.5%) is both a strength (CERKS) and a risk (concentration). International diversification is progressing but from a small base.


Phase 1: Risk Analysis (Munger Inversion)

"Tell me where I'm going to die, so I'll never go there."

Top Risks Register

# Risk Event Probability Severity Expected Loss
1 CERKS revenue cliff post-FY2027 70% -30% -21.0%
2 H1 FY2026 deceleration persists; growth stalls 50% -25% -12.5%
3 Extreme illiquidity causes price dislocation 40% -30% -12.0%
4 Key-man risk: Lee Wan Lik departure 15% -40% -6.0%
5 Competitive displacement by Diligent/Nasdaq 20% -25% -5.0%
6 HK/China political risk affecting government contracts 25% -20% -5.0%
7 Customer concentration (single large client) 30% -15% -4.5%
8 Dividend cut to fund growth 40% -10% -4.0%
9 AI disruption of board governance workflows 10% -25% -2.5%
10 Currency risk (HKD/SGD reporting mismatch) 20% -5% -1.0%
Total Expected Downside -73.5%

Detailed Risk Analysis

Risk 1: CERKS Revenue Cliff (Highest Impact) The HK$1.02B CERKS contract has been the primary growth driver. Implementation revenue (HK$633.9M) is recognized through FY2027. After that, only maintenance revenue (~HK$38M/year) remains. This could create a HK$100M+ annual revenue hole if not replaced by organic Convene growth. The H1 FY2026 results may already be showing the early stages of this deceleration.

Risk 2: Growth Deceleration Already Visible H1 FY2026 (6 months ended Sep 30, 2025) shows concerning trends:

  • Revenue: HK$185.5M (+9.5% YoY vs +44.3% in FY2025)
  • Operating margin: 25.8% (vs 41.7% in FY2025)
  • Net income: HK$48.3M (-1.1% YoY)

The massive margin compression from 41.7% to 25.8% operating margins in H1 suggests the CERKS implementation phase (high-margin licensing) is transitioning to lower-margin deployment work. This is the most immediate concern.

Risk 3: Liquidity/Float Risk Only 17.3% of shares are publicly traded. The founder controls 82.4% through direct and indirect holdings. Average daily volume is only ~6,000 shares (SGD 68,000/day). This means:

  • Institutional investors cannot take meaningful positions
  • Any selling pressure causes outsized price drops
  • Bid-ask spreads can be very wide
  • Exit during a crisis would be extremely difficult

Risk 4: Key-Man Risk Lee Wan Lik (MIT, founder 1991, 35+ years with company) is irreplaceable. He controls the company economically and strategically. His late wife (Lam Pui Wan, deceased) held shares through the estate he administers. CEO Michael Yap was appointed in 2022 and provides operational continuity, but Lee remains the visionary.

Risk 5: Competitive Threat Diligent (backed by Insight Partners, ~$1B+ revenue) is the dominant global board portal provider. Nasdaq Boardvantage and OnBoard are also well-funded competitors. Azeus Convene competes on price, security (CMMI Level 5), and government-grade compliance, but lacks the marketing budget of larger rivals.

Risk 6: Hong Kong Political Risk 63.5% of revenue comes from Hong Kong/Asia. Government contract dependence in Hong Kong creates exposure to political shifts, budget cuts, or changes in procurement policy. The National Security Law and evolving HK-China relations add geopolitical uncertainty.

Tail Risk Scenario

If CERKS winds down without replacement, growth stalls, and the market de-rates from 12x to 8x earnings on a lower base (say HK$100M net income vs HK$167M), the stock could fall to SGD 5-6, representing a -45-55% decline. This is a non-trivial scenario given the H1 FY2026 data.


Phase 2: Financial Analysis

Profitability (5-Year Trend)

Metric FY2021 FY2022 FY2023 FY2024 FY2025 5yr CAGR
Revenue (HK$M) 178.1 217.7 252.9 328.9 474.8 21.7%
Net Income (HK$M) 23.7 48.5 50.5 85.0 166.9 47.9%
EPS (HK$) 0.79 1.62 1.68 2.83 5.56 47.9%
Gross Margin 69.0% 72.4% 72.0% 71.0% 76.6% Expanding
Operating Margin 12.6% 24.7% 23.9% 27.9% 41.7% Expanding
Net Margin 13.3% 22.3% 20.0% 25.8% 35.2% Expanding
ROE 19.9% 31.3% 37.9% 53.4% 74.5% Rising

The profitability trajectory is extraordinary. Revenue has grown 2.7x in 5 years while net income has grown 7x, demonstrating massive operating leverage in the software model. The 76.6% gross margin and 41.7% operating margin in FY2025 are world-class, comparable to elite SaaS companies.

However: FY2025's exceptional margins are partly CERKS-inflated. The H1 FY2026 operating margin of 25.8% is likely a more sustainable baseline. True "core" operating margins are probably 25-30%.

DuPont ROE Decomposition (FY2025)

Component FY2025 FY2024
Net Margin 35.2% 25.8%
Asset Turnover 1.08x 1.02x
Equity Multiplier 1.97x 2.03x
ROE 74.5% 53.4%

The 74.5% ROE is driven primarily by exceptional margins, not leverage. The equity multiplier is low at 2.0x (company has no debt). This is "clean" ROE -- genuine business quality, not financial engineering.

Owner Earnings Calculation (FY2025)

Component HK$'000
Net Income 166,949
+ D&A 7,320
- Maintenance CapEx (est.) (2,000)
- Growth CapEx (1,526)
Owner Earnings ~170,743

Owner earnings per share: HK$5.69 / ~30M shares At current market cap of ~HK$1,950M, owner earnings yield = 8.8%

Free Cash Flow Analysis

Metric FY2021 FY2022 FY2023 FY2024 FY2025
Operating CF (HK$M) 77.6 58.1 35.7 102.3 197.9
CapEx (HK$M) (0.4) (0.6) (1.1) (5.8) (3.5)
FCF (HK$M) 77.2 57.4 34.6 96.5 194.4
FCF/Net Income 326% 118% 68% 114% 116%
FCF Margin 43.4% 26.4% 13.7% 29.3% 40.9%

Cash conversion is excellent. FCF consistently exceeds net income (average 116% conversion) because the business is asset-light, collects customer prepayments (contract liabilities of HK$121M), and requires minimal capital expenditure.

Balance Sheet: Fortress Grade

Metric FY2025
Cash & Bank Deposits HK$270.3M
Total Debt (all lease liabilities) HK$25.0M
Net Cash (ex-leases) HK$270.3M
Net Cash as % of Market Cap ~14%
Current Ratio 2.3x
Bank Borrowings HK$0

The company carries zero financial debt. The only liabilities are operating lease obligations (HK$25M) and deferred revenue/contract liabilities (HK$121M -- a sign of strength, not weakness). Cash of HK$270M represents about 14% of the market cap, providing a substantial cash cushion.

Valuation

Current Multiples:

Multiple Value Adjusted (ex-cash)
P/E (TTM FY2025) 12.3x ~10.6x
EV/EBITDA ~8.5x ~8.5x
P/FCF ~10.0x ~8.6x
EV/Revenue ~3.5x ~3.5x
Dividend Yield 8.2% 8.2%

DCF Valuation:

Assumptions:

  • Base FCF: HK$120M (normalized, below FY2025 peak, above H1 FY2026 run-rate)
  • Growth Rate Years 1-5: 8% (conservative, factoring CERKS wind-down)
  • Growth Rate Years 6-10: 5%
  • Terminal Growth: 2.5%
  • Discount Rate: 12% (Singapore small-cap, illiquidity premium)
Year FCF (HK$M)
1 129.6
2 140.0
3 151.2
4 163.3
5 176.3
6 185.2
7 194.4
8 204.2
9 214.4
10 225.1
Terminal Value 2,430

PV of FCFs: HK$1,015M PV of Terminal: HK$782M Plus Net Cash: HK$270M Enterprise Value: HK$2,067M Per Share: HK$68.9 = SGD 12.0 (at 5.75 HKD/SGD)

DCF Range:

  • Bear Case (6% growth, 13% discount): SGD 9.20
  • Base Case (8% growth, 12% discount): SGD 12.00
  • Bull Case (12% growth, 11% discount): SGD 17.50

Current price of SGD 11.29 sits just below base case fair value, offering limited margin of safety.

Peer Comparison:

Company P/E EV/EBITDA Gross Margin Revenue Growth
Diligent (private) N/A ~15-20x ~75% ~15%
Descartes Systems 55x 35x 79% 20%
Azeus Systems (BBW) 12x 8.5x 77% 44%*

*FY2025 growth inflated by CERKS. Normalized growth likely 10-15%.

Azeus trades at a massive discount to comparable SaaS companies, but this is partly justified by its illiquidity, geographic concentration, and CERKS dependency.


Phase 3: Moat Analysis

Moat Rating: NARROW (with potential to widen)

Moat Source 1: Switching Costs (Primary) Board portal software is deeply embedded in governance workflows. Once a board adopts Convene:

  • Directors are trained on the platform
  • Historical meeting records and documents are stored
  • Integration with Microsoft Teams and other tools is configured
  • Compliance documentation references the platform
  • Switching requires board approval and retraining of senior leadership

Customer retention rates appear very high (evidenced by 91% recurring/contracted revenue). Board governance is a "sticky" category because boards meet regularly and directors are resistant to change.

Moat Source 2: Regulatory & Compliance (Secondary)

  • CMMI Level 5 certification (maintained 20+ years) -- the highest software quality rating
  • ISO 27001, SOC 2 Type II compliance
  • GDPR compliance with data residency options
  • Government-grade security clearances
  • UAE Pass integration for Middle East markets

These certifications and compliance requirements create barriers that smaller competitors cannot easily match and give Azeus access to government and regulated industry procurement processes.

Moat Source 3: Government Contract Lock-In The CERKS contract creates a 10-year maintenance relationship with the Hong Kong government. Once Convene Records is deployed across government departments, switching costs become enormous. This is effectively a franchise for a decade.

Moat Width Assessment:

  • Evidence of pricing power: Gross margins expanding from 69% to 77% over 5 years
  • Evidence of customer retention: 91% recurring/contracted revenue
  • Brand recognition: "Award-winning" product, used in 100+ countries
  • Scale in niche: Among top 5 board portal providers globally

Moat Risk: The moat is narrow rather than wide because:

  1. Diligent is 10x larger and could undercut on price
  2. Board portals are a relatively undifferentiated category (features converge)
  3. The government contracting advantage is geography-specific
  4. No network effects -- each client's use doesn't make the product more valuable for others

Moat Durability: 10-15 years

The switching costs and compliance certifications provide a durable (10+ year) moat, but the company must continue investing in R&D and geographic expansion to prevent erosion by better-funded competitors.


Phase 4: Decision Synthesis

Management Quality Assessment

Lee Wan Lik (Executive Chairman, Founder)

  • MIT-educated (CS + Math), MS Computer Science
  • Founded Azeus in 1991 (35+ years tenure)
  • Controls 82.4% of the company (massive skin in the game)
  • Fellow of Hong Kong Institution of Engineers, British Computer Society
  • Deeply technical founder who remains actively involved in R&D
  • Capital allocation: Near-100% dividend payout, no acquisitions, no dilution
  • Grade: A -- Founder-operator with extreme alignment

Michael Yap (CEO since March 2022)

  • Former deputy CEO of Singapore's Media Development Authority
  • Former CEO of National Computer Board of Singapore
  • Named BusinessWeek's 50 Stars of Asia; WEF Top 100 Future Global Leaders
  • Brings government and enterprise sales expertise
  • Grade: B+ -- Strong operational leader, still proving himself

Capital Allocation: The near-100% payout ratio is unusual for a growth company. It reflects:

  1. The founder's preference to reward shareholders (including himself -- he receives ~82% of dividends)
  2. Very low capital needs (asset-light software)
  3. Inability to deploy cash productively beyond organic growth
  4. May also reflect the company's Bermuda incorporation (no income tax on dividends)

Concern: At 99% payout ratio, there is no margin of safety for a bad year. If earnings drop (as H1 FY2026 suggests), the dividend may need to be cut, which could trigger a selloff.

Position Sizing Framework

Given the analysis, I would allocate this to a 2-3% portfolio position at the right price, with the following considerations:

Positive factors justifying allocation:

  • Founder-operator with 82% ownership
  • 77% gross margins, 25-30% normalized operating margins
  • Fortress balance sheet (zero debt, HK$270M cash)
  • 8%+ dividend yield
  • Growing product business in 100+ countries
  • Trading at ~12x earnings, ~10x ex-cash

Negative factors limiting position size:

  • 17% public float = extreme illiquidity
  • CERKS revenue cliff post-FY2027
  • H1 FY2026 margin compression
  • Single-market concentration (HK/Asia 63.5%)
  • No analyst coverage, minimal institutional ownership
  • Very small company (sub-$300M market cap)

Entry Price Strategy

Price Level Action P/E (approx) FCF Yield
SGD 9.00-9.50 Strong Buy (3% allocation) ~10x ~12-13%
SGD 9.50-10.50 Accumulate (2% allocation) ~11x ~11-12%
SGD 11.00-12.00 Hold (current range) ~12x ~10%
SGD 13.00+ Reduce ~14x ~8.5%

Monitoring Metrics

Metric Threshold Action
H2 FY2026 revenue growth < 5% Reassess thesis
Operating margin (annual) < 20% Investigate cost structure
Convene ARR growth (ex-CERKS) < 10% Moat may be eroding
Dividend cut Any reduction Expected; do not overreact
Lee Wan Lik sells shares Any material sale Exit immediately
Public float drops below 12% Regulatory risk Assess delisting risk
New large government contract Announced Upgrade thesis

Appendix: Key Data Sources

All financial data sourced from:

  1. Azeus Systems Annual Reports FY2021-FY2025 (downloaded PDFs from company IR)
  2. Consolidated financial statements from AR FY2025, pages 44-49 (P&L, BS, CF)
  3. Note 4 (Revenue disaggregation, page 67), Note 30 (Segment info, pages 102-104)
  4. Chairman and CEO's Message (pages 6-7) for business context
  5. Statistics of Shareholdings (pages 104-105) for ownership data
  6. StockAnalysis.com for H1 FY2026 interim data and dividend history
  7. MarketScreener for valuation cross-checks